Haseeb joined the HDR UK Board of Trustees in January 2025. He is a senior leader in the biopharmaceutical industry and has over 25 years of life sciences leadership experience and a distinguished record of building multi-billion dollar brands from primary care to rare disease, across mature and growth markets. He was most recently President for Novartis Europe having previously been President for Novartis Gene Therapies in the US. Prior to this, he was the Global Head of Value & Access and Commercial Development at Novartis and then Managing Director of Novartis UK, Ireland & Nordics.
While at Novartis, Haseeb served as President and Chairman of the Board for the Association of the British Pharmaceutical Industry (ABPI) and also acted as Government Advisor for its Innovation Expert Group. Before joining Novartis, he held a long career with MSD including country Managing Director roles in Ireland and Greece.
Throughout his career, Haseeb has built and led high-performing teams including at leading pharmaceutical companies. He is also a vocal advocate and industry ambassador for expanding access to innovative medicines.